|
|
| Balance Sheet |
|
| Glenmark Pharmaceuticals Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : Glenn Saldanha | | Home : Indian Private | Book Value: 651.2259081 | | BSE Code : 532296 | Market Cap: 29742.63 | | NSE Code : GLENMARK | P / E : 28.26 | |
| |
|
|
|
| (Rs in Cr.) |
 |
 |
| SOURCES OF FUNDS: | | | Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 | | Reserves & Surplus | 17849.25 | 16710.37 | 14781.29 | 13198.05 | 11913.87 | | Total Shareholders Funds | 17877.47 | 16738.59 | 14809.51 | 13226.27 | 11942.09 | | Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 6.11 | | Unsecured Loans | 3593.80 | 3859.02 | 3840.60 | 3779.41 | 3216.88 | | Total Debt | 3593.80 | 3859.02 | 3840.60 | 3779.41 | 3222.99 | | Total Liabilities | 21471.27 | 20597.61 | 18650.11 | 17005.68 | 15165.08 | | APPLICATION OF FUNDS: | | Gross Block | 3183.65 | 3026.28 | 2848.56 | 2595.06 | 2260.10 | | Less: Accum. Depreciation | 1437.70 | 1273.95 | 1126.07 | 983.11 | 846.62 | | Net Block | 1745.95 | 1752.33 | 1722.49 | 1611.95 | 1413.48 | | Capital Work in Progress | 172.34 | 109.04 | 131.40 | 200.01 | 286.20 | | Investments | 10334.01 | 8559.39 | 6989.95 | 4713.93 | 3268.75 | | Inventories | 1090.21 | 951.66 | 762.39 | 837.50 | 911.21 | | Sundry Debtors | 2505.66 | 2678.32 | 2488.75 | 1835.24 | 2087.13 | | Cash and Bank Balance | 93.79 | 29.63 | 15.79 | 88.26 | 256.48 | | Loans and Advances | 8857.46 | 9048.32 | 8772.19 | 9941.31 | 9270.54 | | Current Liabilities | 3165.64 | 2382.59 | 2099.74 | 2104.08 | 2206.96 | | Provisions | 162.52 | 148.49 | 133.11 | 118.45 | 121.75 | | Net Current Assets | 9218.96 | 10176.85 | 9806.27 | 10479.78 | 10196.65 | | Miscellaneous Expenses not w/o | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Total Assets | 21471.26 | 20597.61 | 18650.11 | 17005.67 | 15165.08 | | Contingent Liabilities | 3443.30 | 3325.06 | 3730.17 | 4430.59 | 3680.94 |
|
|
|
|
|